Search Query :
4NH8
Correlation between chemotype-dependent binding conformations of hsp90 alpha/beta and isoform selectivity Deposition Author(s): Ernst, J.T. , Zuccola, H.J.
Date: 2013-11-04 Method: X-RAY DIFFRACTION Resolution: 1.65 Å Organism(s): Homo Sapiens Sequences Data: 4NH8_A
4NH9
Correlation between chemotype-dependent binding conformations of hsp90 alpha/beta and isoform selectivity Deposition Author(s): Ernst, J.T. , Zuccola, H.J.
Date: 2013-11-04 Method: X-RAY DIFFRACTION Resolution: 2.77 Å Organism(s): Homo Sapiens Sequences Data: 4NH9_A
4O05
Identification of novel hsp90/isoform selective inhibitors using structure-based drug design. demonstration of potential utility in treating cns disorders such as huntington's disease Deposition Author(s): Ernst, J.T. , Zuccola, H.J.
Date: 2013-12-13 Method: X-RAY DIFFRACTION Resolution: 1.79 Å Organism(s): Homo Sapiens Sequences Data: 4O05_A
4O07
Identification of novel hsp90/isoform selective inhibitors using structure-based drug design. demonstration of potential utility in treating cns disorders such as huntington's disease Deposition Author(s): Ernst, J.T. , Zuccola, H.J.
Date: 2013-12-13 Method: X-RAY DIFFRACTION Resolution: 1.86 Å Organism(s): Homo Sapiens Sequences Data: 4O07_A
4O09
Identification of novel hsp90 / isoform selective inhibitors using structure-based drug design. demonstration of potential utility in treating cns disorders such as huntington s disease Deposition Author(s): Ernst, J.T. , Zuccola, H.J.
Date: 2013-12-13 Method: X-RAY DIFFRACTION Resolution: 1.96 Å Organism(s): Homo Sapiens Sequences Data: 4O09_A
4O0B
Identification of novel hsp90/isoform selective inhibitors using structure-based drug design. demonstration of potential utility in treating cns disorders such as huntington's disease Deposition Author(s): Ernst, J.T. , Zuccola, H.J.
Date: 2013-12-13 Method: X-RAY DIFFRACTION Resolution: 1.93 Å Organism(s): Homo Sapiens Sequences Data: 4O0B_A